Literature DB >> 7688377

Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.

M Krieg1, R Nass, S Tunn.   

Abstract

It is widely believed that benign prostatic hyperplasia (BPH) is associated with aging. Thus, the question arises whether or not a correlation exists between the well known prostatic androgen and estrogen accumulation and aging. To address this question, we measured 5 alpha-dihydrotestosterone (DHT), testosterone, estradiol, and estrone in epithelium and stroma of six normal (NPR) and 19 BPH and correlated the values with the age of the donors (26-87 yr). The mean DHT level in NPR epithelium was significantly higher than in NPR stroma, and also significantly higher than in epithelium and stroma of BPH. The epithelial DHT level of NPR and BPH decreased with age, the correlation being statistically significant. The stromal DHT level of NPR and BPH showed no correlation with age. Concerning testosterone, generally rather low values were found which showed no correlation with age. The mean levels of estradiol and estrone were significantly higher in BPH stroma as compared to BPH epithelium as well as to NPR epithelium and stroma. In NPR, the mean levels of estradiol and estrone were significantly higher in epithelium than stroma. In NPR and BPH, the stromal estradiol and estrone levels increased significantly with age. In epithelium such a correlation between the estrogen levels and age was not found. Our results indicate that the prostatic accumulation of DHT, estradiol, and estrone is in part intimately correlated with aging, leading with increasing age to a dramatic increase of the estrogen/androgen ratio particularly in stroma of BPH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688377     DOI: 10.1210/jcem.77.2.7688377

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.

Authors:  Joseph John Bianco; Stephen John McPherson; Hong Wang; Gail S Prins; Gail Petuna Risbridger
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  Testosterone levels among Aché hunter-gatherer men : A functional interpretation of population variation among adult males.

Authors:  R G Bribiescas
Journal:  Hum Nat       Date:  1996-06

3.  High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.

Authors:  Zakaria Y Abd Elmageed; Krzysztof Moroz; Sudesh K Srivastav; Zhide Fang; Byron E Crawford; Krishnarao Moparty; Raju Thomas; Asim B Abdel-Mageed
Journal:  Carcinogenesis       Date:  2013-05-08       Impact factor: 4.944

Review 4.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

5.  Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.

Authors:  Fabio Montico; Larissa Akemi Kido; Amanda Cia Hetzl; Raísa Mistieri Lorencini; Eduardo Marcelo Cândido; Valéria Helena Alves Cagnon
Journal:  Histochem Cell Biol       Date:  2014-02-22       Impact factor: 4.304

6.  Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men.

Authors:  Jenny Pena Dias; Denise Melvin; Michelle Shardell; Luigi Ferrucci; Chee W Chia; Mohsen Gharib; Josephine M Egan; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2016-03-07       Impact factor: 5.958

Review 7.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Prostatic microenvironment in senescence: fibroblastic growth factors × hormonal imbalance.

Authors:  A C Hetzl; F Montico; R M Lorencini; L A Kido; E M Cândido; V H A Cagnon
Journal:  Histochem Cell Biol       Date:  2013-12-22       Impact factor: 4.304

9.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.